RT @UKCochraneCentr: Updated #CochraneEvidence on anthracycline chemotherapy & cardiotoxicity https://t.co/42PjTcEVnv @CR_UK @oh_henry
RT @UKCochraneCentr: Updated #CochraneEvidence on anthracycline chemotherapy & cardiotoxicity https://t.co/42PjTcEVnv @CR_UK @oh_henry
"Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy" https://t.co/U430DROYsp
RT @gedefo_sefh: "Different dosage schedules for reducing damage to the heart in people with cancer receiving anthracycline" https://t.co/b…
Different dosage schedules for reducing cardiotoxicity in people with #cancer receiving anthracycline chemotherapy https://t.co/llMyE195A6
"Different dosage schedules for reducing damage to the heart in people with cancer receiving anthracycline" https://t.co/bZvDJBib3K
Different dosage schedules for reducing damage to the heart in people with cancer receiving… https://t.co/TcWzZnWcrP
Determining the occurrence of cardiotoxicity with the use of different anthracycline dosage schedules https://t.co/J98twbMHHJ